Investors could be overestimating the contribution of Hims & Hers' compounded GLP-1 medications to its top line. Read why I ...
Is Hims & Hers a millionaire-maker in the making? Yes! Or, at least, it can be. There is a possible future where Hims & Hers ...
Hims & Hers (HIMS) stock dips as Morgan Stanley downgrades the telehealth firm citing its recent rally in share price. Read more here.
It’s normal to have lots of questions when you start a new prescription medication. Whether you can drink alcohol might be at ...
19h
Stocktwits on MSNHims & Hers Stock: More Gains Ahead Or A Pullback? Most Retail Traders Bet On This PathHims & Hers Health Inc. has been on a meteoric rise, with shares soaring over 145% this year and more than sixfold in the ...
14h
Hosted on MSNHims & Hers: From Viral Ad to Volatile StockHims & Hers Health's (NYSE: HIMS) share price has surged recently, climbing above $60 and creating new 52-week and all-time ...
When celebrities reveal their experiences with newer weight-loss drugs, there are upsides and downsides for patients and ...
Semaglutide (Wegovy and Ozempic): Originally developed for type 2 diabetes, this medication mimics the GLP-1 hormone, ...
Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results